 |
|
|
| |
High-Dose VH3810109 (N6LS) ± Recombinant Human
Hyaluronidase PH20: Phase 1 SPAN Study Safety Results
|
| |
| |
CROI 2024 March 3-6 Denver
Beta Win, 1 Peter Leone, 2 Jan Losos, 2 Paul Wannamaker, 2 Riccardo D’Agostino, 1 Michael Warwick-Sanders, 1 Gabriela L. Ghita, 3 Viviana Wilches, 3 Max Lataillade 4
1 GSK, Brentford, UK; 2 ViiV Healthcare, Durham, NC, USA; 3 GSK, Collegeville, PA, USA; 4 ViiV Healthcare, Branford, CT, USA
|
| |
|
|
|
|
|
